Beta-Blockers after Myocardial Infarction: Do Benefits Ever Outweigh Risks in Asthma?
Authors:
- Judith E. SobermanJSJudith E. Soberman
- Kutay DemirkanKDKutay Demirkan
- Timothy SelfTSTimothy Self
- 1 January 1999
- journal article
- review article
- Published by S. Karger AG in Cardiology
- Vol. 92 (2) , 99-105
Abstract
β-Blockers are well documented to prolong life in patients after myocardial infarction (MI), yet patients who also have asthma are frequently and understandably denied this therapy. We reviewed the literature (via MEDLINE) for the past 35 years for β-blocker-induced asthma, and reexamined potential β-blocker use in the context of NIH guidelines for asthma classification and management. Because β-blockers can cause fatal or life-threatening asthma, their use should be avoided in moderate to severe persistent asthmatics. Benefits of low-dose β1-blockers (e.g. atenolol 50 mg daily) may outweigh risks in some patients with mild intermittent or well-controlled mild persistent asthma. Further study is needed to verify that low doses of β1-blockers are effective in prolonging life after MI, and that use specifically in mild intermittent or mild persistent asthma per NIH classification is safe.Keywords
This publication has 8 references indexed in Scilit:
- Effect of Beta-Blockade on Mortality among High-Risk and Low-Risk Patients after Myocardial InfarctionNew England Journal of Medicine, 1998
- β-Blocker Dosages and Mortality After Myocardial InfarctionArchives of internal medicine (1960), 1998
- β-Blocker–Induced Complications and the Patient With GlaucomaArchives of internal medicine (1960), 1998
- Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmaticsThe Lancet, 1997
- ACC/AHA guidelines for the management of patients with acute myocardial infarctionJACC, 1996
- Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project1995
- Secondary prevention after high-risk acute myocardial infarction with low-dose acebutololThe American Journal of Cardiology, 1990
- A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality resultsJAMA, 1982